Skip to main content
Erschienen in:

07.06.2021 | Breast Oncology

Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care

verfasst von: Callisia N. Clarke, MD, MS, FACS, FSSO, Chandler S. Cortina, MD, Oluwadamilola M. Fayanju, MD, MA, MPHS, Lesly A. Dossett, MD, MPH, Fabian M. Johnston, MD, MHS, Sandra L. Wong, MD, MS

Erschienen in: Annals of Surgical Oncology | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

The Society of Surgical Oncology is committed to reducing health disparities adversely affecting sexual and gender minorities. Transgender persons represent a socially disadvantaged group who frequently experience discrimination and receive disparate care, resulting in suboptimal cancer outcomes. The rate of breast cancer development in transgender individuals differs from rates observed in their cisgender counterparts, however there is little evidence to quantify these differences and guide evidence-based screening and prevention. There is no consensus for breast cancer screening guidelines in transgender patients. In this review, we discuss barriers to equitable breast cancer care, risk factors for breast cancer development, and existing data to support breast cancer screening in transgender men and women.
Literatur
2.
Zurück zum Zitat Diamant AL, et al. Health behaviors, health status, and access to and use of health care: a population-based study of lesbian, bisexual, and heterosexual women. Arch Fam Med. 2000;9(10):1043–51.CrossRef Diamant AL, et al. Health behaviors, health status, and access to and use of health care: a population-based study of lesbian, bisexual, and heterosexual women. Arch Fam Med. 2000;9(10):1043–51.CrossRef
3.
Zurück zum Zitat Austin SB, et al. An examination of sexual orientation group patterns in mammographic and colorectal screening in a cohort of U.S. women. Cancer Causes Control. 2013;24(3):539–47.CrossRef Austin SB, et al. An examination of sexual orientation group patterns in mammographic and colorectal screening in a cohort of U.S. women. Cancer Causes Control. 2013;24(3):539–47.CrossRef
4.
Zurück zum Zitat Blosnich JR, et al. Health inequalities among sexual minority adults: evidence from ten U.S. states, 2010. Am J Prev Med. 2014;46(4):337–49.CrossRef Blosnich JR, et al. Health inequalities among sexual minority adults: evidence from ten U.S. states, 2010. Am J Prev Med. 2014;46(4):337–49.CrossRef
5.
Zurück zum Zitat Quinn GP, et al. Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA Cancer J Clin. 2015;65(5):384–400.CrossRef Quinn GP, et al. Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA Cancer J Clin. 2015;65(5):384–400.CrossRef
6.
Zurück zum Zitat Burns ZT, et al. Clinical characteristics, experiences, and outcomes of transgender patients with cancer. JAMA Oncol. 2021;7(1):e205671.CrossRef Burns ZT, et al. Clinical characteristics, experiences, and outcomes of transgender patients with cancer. JAMA Oncol. 2021;7(1):e205671.CrossRef
7.
Zurück zum Zitat Hartley RL, Stone JP, Temple-Oberle C. Breast cancer in transgender patients: a systematic review. Part 1: male to female. Eur J Surg Oncol. 2018;44(10):1455–62.CrossRef Hartley RL, Stone JP, Temple-Oberle C. Breast cancer in transgender patients: a systematic review. Part 1: male to female. Eur J Surg Oncol. 2018;44(10):1455–62.CrossRef
8.
Zurück zum Zitat Stone JP, Hartley RL, Temple-Oberle C. Breast cancer in transgender patients: a systematic review. Part 2: female to male. Eur J Surg Oncol. 2018;44(10):1463–8.CrossRef Stone JP, Hartley RL, Temple-Oberle C. Breast cancer in transgender patients: a systematic review. Part 2: female to male. Eur J Surg Oncol. 2018;44(10):1463–8.CrossRef
9.
Zurück zum Zitat Fledderus AC, et al. Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening. Breast. 2020;53:92–100.CrossRef Fledderus AC, et al. Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening. Breast. 2020;53:92–100.CrossRef
10.
Zurück zum Zitat Unger CA. Care of the transgender patient: a survey of gynecologists’ current knowledge and practice. J Womens Health (Larchmt). 2015;24(2):114–8.CrossRef Unger CA. Care of the transgender patient: a survey of gynecologists’ current knowledge and practice. J Womens Health (Larchmt). 2015;24(2):114–8.CrossRef
11.
Zurück zum Zitat Bradford J, et al. Experiences of transgender-related discrimination and implications for health: results from the Virginia Transgender Health Initiative Study. Am J Public Health. 2013;103(10):1820–9.CrossRef Bradford J, et al. Experiences of transgender-related discrimination and implications for health: results from the Virginia Transgender Health Initiative Study. Am J Public Health. 2013;103(10):1820–9.CrossRef
12.
Zurück zum Zitat Hughto JMW, Pachankis JE, Reisner SL. Healthcare Mistreatment and Avoidance in Trans Masculine Adults: The Mediating Role of Rejection Sensitivity. Psychol Sex Orientat Gend Divers. 2018;5(4):471–81.CrossRef Hughto JMW, Pachankis JE, Reisner SL. Healthcare Mistreatment and Avoidance in Trans Masculine Adults: The Mediating Role of Rejection Sensitivity. Psychol Sex Orientat Gend Divers. 2018;5(4):471–81.CrossRef
13.
Zurück zum Zitat Socias ME, et al. Factors associated with healthcare avoidance among transgender women in Argentina. Int J Equity Health. 2014;13(1):81.CrossRef Socias ME, et al. Factors associated with healthcare avoidance among transgender women in Argentina. Int J Equity Health. 2014;13(1):81.CrossRef
14.
Zurück zum Zitat Johnson CV, Mimiaga MJ, Bradford J. Health care issues among lesbian, gay, bisexual, transgender and intersex (LGBTI) populations in the United States: Introduction. J Homosex. 2008;54(3):213–24.CrossRef Johnson CV, Mimiaga MJ, Bradford J. Health care issues among lesbian, gay, bisexual, transgender and intersex (LGBTI) populations in the United States: Introduction. J Homosex. 2008;54(3):213–24.CrossRef
15.
Zurück zum Zitat Griggs J, et al. American society of clinical oncology position statement: strategies for reducing cancer health disparities among sexual and gender minority populations. J Clin Oncol. 2017;35(19):2203–8.CrossRef Griggs J, et al. American society of clinical oncology position statement: strategies for reducing cancer health disparities among sexual and gender minority populations. J Clin Oncol. 2017;35(19):2203–8.CrossRef
16.
Zurück zum Zitat Brown GR, Jones KT. Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Res Treat. 2015;149(1):191–8.CrossRef Brown GR, Jones KT. Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Res Treat. 2015;149(1):191–8.CrossRef
17.
Zurück zum Zitat Gooren LJ. Clinical practice. Care of transsexual persons. N Engl J Med. 2011;364(13):1251–7.CrossRef Gooren LJ. Clinical practice. Care of transsexual persons. N Engl J Med. 2011;364(13):1251–7.CrossRef
18.
Zurück zum Zitat Wierckx K, et al. Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med. 2012;9(10):2641–51.CrossRef Wierckx K, et al. Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med. 2012;9(10):2641–51.CrossRef
19.
Zurück zum Zitat de Blok CJM, et al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ. 2019;365:l1652.CrossRef de Blok CJM, et al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ. 2019;365:l1652.CrossRef
20.
Zurück zum Zitat Gooren LJ, et al. Breast cancer development in transsexual subjects receiving cross-sex hormone treatment. J Sex Med. 2013;10(12):3129–34.CrossRef Gooren LJ, et al. Breast cancer development in transsexual subjects receiving cross-sex hormone treatment. J Sex Med. 2013;10(12):3129–34.CrossRef
21.
Zurück zum Zitat Burcombe RJ, et al. Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. Breast. 2003;12(4):290–3.CrossRef Burcombe RJ, et al. Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. Breast. 2003;12(4):290–3.CrossRef
22.
Zurück zum Zitat Nikolic DV, et al. Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy. World J Surg Oncol. 2012;10:280.CrossRef Nikolic DV, et al. Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy. World J Surg Oncol. 2012;10:280.CrossRef
23.
Zurück zum Zitat Gooren L, et al. Five new cases of breast cancer in transsexual persons. Andrologia. 2015;47(10):1202–5.CrossRef Gooren L, et al. Five new cases of breast cancer in transsexual persons. Andrologia. 2015;47(10):1202–5.CrossRef
24.
Zurück zum Zitat Katayama Y, et al. A very rare case of breast cancer in a female-to-male transsexual. Breast Cancer. 2016;23(6):939–44.CrossRef Katayama Y, et al. A very rare case of breast cancer in a female-to-male transsexual. Breast Cancer. 2016;23(6):939–44.CrossRef
25.
Zurück zum Zitat Shao T, Grossbard ML, Klein P. Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management. Clin Breast Cancer. 2011;11(6):417–9.CrossRef Shao T, Grossbard ML, Klein P. Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management. Clin Breast Cancer. 2011;11(6):417–9.CrossRef
26.
Zurück zum Zitat Ray A, et al. Testosterone therapy and risk of breast cancer development: a systematic review. Curr Opin Urol. 2020;30(3):340–8.CrossRef Ray A, et al. Testosterone therapy and risk of breast cancer development: a systematic review. Curr Opin Urol. 2020;30(3):340–8.CrossRef
27.
Zurück zum Zitat Parikh U, et al. Breast Imaging in Transgender Patients: What the Radiologist Should Know. Radiographics. 2020;40(1):13–27.CrossRef Parikh U, et al. Breast Imaging in Transgender Patients: What the Radiologist Should Know. Radiographics. 2020;40(1):13–27.CrossRef
28.
Zurück zum Zitat Kiran T, et al. Cancer screening rates among transgender adults: cross-sectional analysis of primary care data. Can Fam Physician. 2019;65(1):e30–7.PubMedPubMedCentral Kiran T, et al. Cancer screening rates among transgender adults: cross-sectional analysis of primary care data. Can Fam Physician. 2019;65(1):e30–7.PubMedPubMedCentral
30.
Zurück zum Zitat Makadon HJ, Mayer KH, Potter J, Goldhammer H. Fenway guide to Lesbian, Gay, bisexual and transgender Health. 2nd ed. American College of Physicians; 2015. Makadon HJ, Mayer KH, Potter J, Goldhammer H. Fenway guide to Lesbian, Gay, bisexual and transgender Health. 2nd ed. American College of Physicians; 2015.
34.
Zurück zum Zitat Hembree WC, et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(9):3132–54.CrossRef Hembree WC, et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(9):3132–54.CrossRef
Metadaten
Titel
Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care
verfasst von
Callisia N. Clarke, MD, MS, FACS, FSSO
Chandler S. Cortina, MD
Oluwadamilola M. Fayanju, MD, MA, MPHS
Lesly A. Dossett, MD, MPH
Fabian M. Johnston, MD, MHS
Sandra L. Wong, MD, MS
Publikationsdatum
07.06.2021
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 4/2022
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-021-10217-5

Neu im Fachgebiet Chirurgie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Appendizitis und Darminfarkt durch Blinddarm-Lipom

Eigentlich sind Lipome recht harmlos. Im Zäkum können sie jedoch erhebliche Komplikationen mit Darminfarkt und Appendizitis verursachen.

Gluteuslappen nach Rektumkarzinom-Op. schützt vor Abszessen

Die Wunddeckung mit einem autologen Rotationslappen nach Entfernung eines Rektumkarzinoms konnte in einer randomisierten Studie gegenüber dem primären Wundverschluss vor allem in einer Hinsicht punkten: Sie führte deutlich seltener zu präsakralen Abszessen.

MedTalk Leitlinie KOMPAKT: S3-Leitline zu peripheren Nervenverletzungen

  • Webinar | 10.02.2025 | 13:00

Über den Weg zur finalen Fassung der S3-Leitlinie "Versorgung peripherer Nervenverletzungen" sprechen Prof. Dr. Leila Harhaus-Wähner und Ressortleiter Dr. Gunter Freese im WebTalk Leitlinie KOMPAKT, einer neuen Webcast-Serie von SpringerMedizin passend zu Ihrem Fachmagazin Orthopädie und Unfallchirurgie Mitteilungen und Nachrichten. In dem kurzen Video geht es darum, was sich im Vergleich zur vorigen Fassung der Leitlinie geändert hat, welche Aspekte für die tägliche Praxis besonders wichtig sind und was jeder gemäß Leitlinie nun anders oder besser machen sollte.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.